YALE-MAYO FDA CENTER FOR EXCELLENCE IN REGULATORY SCIENCE AND INNOVATION
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Research center advancing pharmaceutical and biomedical device regulation through collaborative innovation in regulatory science.
Better regulatory science accelerates safe drug approvals and strengthens U.S. pharmaceutical innovation competitiveness globally.
Regulatory innovations may accelerate approval timelines for pharmaceutical manufacturing and medical device supply chains.
U.S. regulatory science excellence provides competitive advantage over China in pharmaceutical and biomedical device markets.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-15. Cost: $0.027293.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_U01FD005938_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.